Clinical trials on Ayurvedic drugs
||The topic of this article may not meet Wikipedia's general notability guideline. (April 2015)|
|This article needs additional citations for verification. (April 2015)|
|This article relies too much on references to primary sources. (April 2015)|
Reverse pharmacology is one of the approaches to clinical trials on Ayurvedic drugs.
The U.S. National Institutes of Health states that "Most clinical trials of Ayurvedic approaches have been small, had problems with research designs, or lacked appropriate control groups, potentially affecting research results."
The Indian Council of Medical Research has issued guidance on conducting trials of ayurvedic substances. It says the substances must adhere to the recipes traditionally used and care must be taken to ensure there is no contamination of plant ingredients (e.g., by herbicides).
The government of India has come up with a draft of the guidelines.
- "Ethical guidelines for biomedical research on human participants" (PDF). Indian Council of Medical Research. 2006. Retrieved 19 October 2013.
- "Ayurvedic medicine". Cancer Research UK. Retrieved August 2013.